Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
Gheath Alatrash, Navneet S Majhail, James C Pile
Mayo Clinic proceedings April 1, 2006 Peer reviewed DOI: 10.4065/81.4.550 via PubMed
Summary
A healthy 23-year-old man ingested foxy methoxy and experienced serious health issues, including rhabdomyolysis and temporary acute renal failure. Foxy methoxy is a hallucinogenic drug that has been increasingly abused since the late 1990s and can cause various adverse effects such as restlessness and gastrointestinal distress. The lack of detection in standard toxicology tests raises concerns about additional potential adverse effects.
Study at a glance
| Sample size | 1 |
|---|---|
| Population | a healthy 23-year-old man |
| Key finding | Ingestion of foxy methoxy resulted in rhabdomyolysis and transient acute renal failure. |
Abstract
"Foxy methoxy" (chemical name, 5-methoxy-N,N-diisopropyltryptamine) is a hallucinogenic tryptamine that has been abused with increasing frequency since its appearance in the late 1990s. Like other drugs in this class, foxy frequently produces feelings of euphoria, disinhibition, and auditory as well as visual hallucinations. The drug has been linked to adverse effects, including restlessness, agitation, gastrointestinal distress, and muscle tension. In light of the relatively recent advent of foxy as a drug of abuse and given the inability of commercial toxicologic screening tests to detect the presence of hallucinogenic tryptamines, additional adverse effects seem probable. We report ingestion of foxy by a healthy 23-year-old man that resulted in rhabdomyolysis and transient acute renal failure.